Apposite Capital LLP acquires 1MED SA as part of its healthcare portfolio

Private equity investor Apposite Capital LLP ("Apposite") acquires 1MED SA ("1MED"), a Swiss firm specialising in clinical research and assistance services to MedTech companies seeking regulatory approval for new pharmaceuticals and medical devices. 1MED is a fast-growing organisation offering regulatory strategy, clinical trial management and quality assurance services in the in the medical devices space.

Baker McKenzie advised Apposite on all Swiss law and English law aspects relating to the financing of the acquisition of 1MED. The team was led by Samuel Marbacher (Partner, Banking & Finance) and Philip Spoerlé (Senior Associate, Banking & Finance) and further comprised Manuel Meyer (Partner, Transactions), Cora Schmid (Associate, Banking & Finance), Manuel Hirlinger (Junior Associate, Banking & Finance) in Zurich and Nick Tostivin (Partner, Banking & Finance), Hannah Budenberg (Associate, Banking & Finance) and Lucy Robertson (Junior Associate, Banking & Finance) in London.